Table of Contents

Executive Summary

1 Industry Overview of Antihelminthics

• 1.1 Definition of Antihelminthics
• 1.2 Antihelminthics Segment by Type
  • 1.2.1 Global Antihelminthics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Benzimidazoles
  • 1.2.3 Abamectin
  • 1.2.4 Salicylanilides
  • 1.2.5 Praziquantel
  • 1.2.6 Other
• 1.3 Antihelminthics Segment by Applications
  • 1.3.1 Global Antihelminthics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Schistosomiasis
  • 1.3.3 Fasciolasis
  • 1.3.4 Filariasis
  • 1.3.5 Angiostrongylosis
  • 1.3.6 Ascariasis
  • 1.3.7 Giardiasis
  • 1.3.8 Other
• 1.4 Global Antihelminthics Overall Market
  • 1.4.1 Global Antihelminthics Revenue (2014-2025)
  • 1.4.2 Global Antihelminthics Production (2014-2025)
  • 1.4.3 North America Antihelminthics Status and Prospect (2014-2025)
  • 1.4.4 Europe Antihelminthics Status and Prospect (2014-2025)
  • 1.4.5 China Antihelminthics Status and Prospect (2014-2025)
  • 1.4.6 Japan Antihelminthics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Antihelminthics Status and Prospect (2014-2025)
  • 1.4.8 India Antihelminthics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Antihelminthics
• 2.3 Manufacturing Process Analysis of Antihelminthics
• 2.4 Industry Chain Structure of Antihelminthics

3 Development and Manufacturing Plants Analysis of Antihelminthics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Antihelminthics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Antihelminthics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Antihelminthics Production and Capacity Analysis
• 4.2 Antihelminthics Revenue Analysis
• 4.3 Antihelminthics Price Analysis
• 4.4 Market Concentration Degree

5 Antihelminthics Regional Market Analysis

• 5.1 Antihelminthics Production by Regions
  • 5.1.1 Global Antihelminthics Production by Regions
  • 5.1.2 Global Antihelminthics Revenue by Regions
• 5.2 Antihelminthics Consumption by Regions
• 5.3 North America Antihelminthics Market Analysis
  • 5.3.1 North America Antihelminthics Production
  • 5.3.2 North America Antihelminthics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Antihelminthics Import and Export
• 5.4 Europe Antihelminthics Market Analysis
  • 5.4.1 Europe Antihelminthics Production
  • 5.4.2 Europe Antihelminthics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Antihelminthics Import and Export
• 5.5 China Antihelminthics Market Analysis
  • 5.5.1 China Antihelminthics Production
  • 5.5.2 China Antihelminthics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Antihelminthics Import and Export
• 5.6 Japan Antihelminthics Market Analysis
  • 5.6.1 Japan Antihelminthics Production
  • 5.6.2 Japan Antihelminthics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Antihelminthics Import and Export
• 5.7 Southeast Asia Antihelminthics Market Analysis
  • 5.7.1 Southeast Asia Antihelminthics Production
  • 5.7.2 Southeast Asia Antihelminthics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Antihelminthics Import and Export
• 5.8 India Antihelminthics Market Analysis
  • 5.8.1 India Antihelminthics Production
  • 5.8.2 India Antihelminthics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Antihelminthics Import and Export

6 Antihelminthics Segment Market Analysis (by Type)

• 6.1 Global Antihelminthics Production by Type
• 6.2 Global Antihelminthics Revenue by Type
• 6.3 Antihelminthics Price by Type

7 Antihelminthics Segment Market Analysis (by Application)

• 7.1 Global Antihelminthics Consumption by Application
• 7.2 Global Antihelminthics Consumption Market Share by Application (2014-2019)

8 Antihelminthics Major Manufacturers Analysis

• 8.1 Abbott
  • 8.1.1 Abbott Antihelminthics Production Sites and Area Served
  • 8.1.2 Abbott Product Introduction, Application and Specification
  • 8.1.3 Abbott Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novartis
  • 8.2.1 Novartis Antihelminthics Production Sites and Area Served
  • 8.2.2 Novartis Product Introduction, Application and Specification
  • 8.2.3 Novartis Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 ZEISS International
  • 8.3.1 ZEISS International Antihelminthics Production Sites and Area Served
  • 8.3.2 ZEISS International Product Introduction, Application and Specification
  • 8.3.3 ZEISS International Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Johnson & Johnson
  • 8.4.1 Johnson & Johnson Antihelminthics Production Sites and Area Served
  • 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.4.3 Johnson & Johnson Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Sanofi
  • 8.5.1 Sanofi Antihelminthics Production Sites and Area Served
  • 8.5.2 Sanofi Product Introduction, Application and Specification
  • 8.5.3 Sanofi Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Merck & Co.
  • 8.6.1 Merck & Co. Antihelminthics Production Sites and Area Served
  • 8.6.2 Merck & Co. Product Introduction, Application and Specification
  • 8.6.3 Merck & Co. Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 GlaxoSmithKline
  • 8.7.1 GlaxoSmithKline Antihelminthics Production Sites and Area Served
  • 8.7.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.7.3 GlaxoSmithKline Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Astellas Pharma
  • 8.8.1 Astellas Pharma Antihelminthics Production Sites and Area Served
  • 8.8.2 Astellas Pharma Product Introduction, Application and Specification
  • 8.8.3 Astellas Pharma Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Bayer
  • 8.9.1 Bayer Antihelminthics Production Sites and Area Served
  • 8.9.2 Bayer Product Introduction, Application and Specification
  • 8.9.3 Bayer Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Mentis Pharma
  • 8.10.1 Mentis Pharma Antihelminthics Production Sites and Area Served
  • 8.10.2 Mentis Pharma Product Introduction, Application and Specification
  • 8.10.3 Mentis Pharma Antihelminthics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pfizer
• 8.12 Sanofi
• 8.13 ALLERGAN
• 8.14 AstraZeneca

9 Development Trend of Analysis of Antihelminthics Market

• 9.1 Global Antihelminthics Market Trend Analysis
  • 9.1.1 Global Antihelminthics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Antihelminthics Regional Market Trend
  • 9.2.1 North America Antihelminthics Forecast 2019-2025
  • 9.2.2 Europe Antihelminthics Forecast 2019-2025
  • 9.2.3 China Antihelminthics Forecast 2019-2025
  • 9.2.4 Japan Antihelminthics Forecast 2019-2025
  • 9.2.5 Southeast Asia Antihelminthics Forecast 2019-2025
  • 9.2.6 India Antihelminthics Forecast 2019-2025
• 9.3 Antihelminthics Market Trend (Product Type)
• 9.4 Antihelminthics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Antihelminthics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.

The global Antihelminthics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antihelminthics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antihelminthics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antihelminthics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antihelminthics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott
Novartis
ZEISS International
Johnson & Johnson
Sanofi
Merck & Co.
GlaxoSmithKline
Astellas Pharma
Bayer
Mentis Pharma
Pfizer
Sanofi
ALLERGAN
AstraZeneca

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Benzimidazoles
Abamectin
Salicylanilides
Praziquantel
Other

Segment by Application
Schistosomiasis
Fasciolasis
Filariasis
Angiostrongylosis
Ascariasis
Giardiasis
Other